|
|
|
|
||
Re: Running Out of CashEither your invested for the final outcome of Syn potentials. Or your over positioned short term. It is obvious that the entire investment markets pharmaceutical merger Of companys has completely outplayed the investor. This was greatly signaled by the past history of the large active investor Trying to force action preferred perspective movements. Large institutional holders stabilize investment environments such as Syn so that the High risk of such can produce the big unmet need breakthrough in treatment that Syn Has within their pipeline. A long perspective requires allowance. I have plenty of allowance afforded with all the P2 data completed and submitted Unto both Affiliates and government agencies of medical review, having jurisdiction and Authority control by which Governs the long perspective approach of our submitted highly effective treatments. |
return to message board, top of board |